{ "labelLang" : "hun", "responseDate" : "2024-03-28 10:43", "content" : { "otype" : "BookChapter", "mtid" : 25749999, "status" : "ADMIN_APPROVED", "published" : true, "comment" : "Export Date: 15 April 2019 \n Correspondence Address: Montserrat, E.; Institute of Hematology and Oncology, Hospital Clínic, University of Barcelona, Barcelona, Spain", "unhandledTickets" : 0, "oldTimestamp" : "2016-05-24T11:32:05.000+0000", "deleted" : false, "oldId" : 15749999, "lastRefresh" : "2023-06-21T12:08:28.955+0000", "lastModified" : "2016-05-24T11:32:05.000+0000", "created" : "2016-05-23T12:27:05.000+0000", "creator" : { "otype" : "Author", "mtid" : 10000495, "link" : "/api/author/10000495", "label" : "Matolcsy András (Pathológia)", "familyName" : "Matolcsy", "givenName" : "András", "published" : true, "oldId" : 10000495, "snippet" : true }, "lastDuplumOK" : "2023-06-21T12:07:10.259+0000", "lastDuplumSearch" : "2023-06-14T13:04:51.290+0000", "adminApproved" : "2016-05-24T11:22:43.000+0000", "adminApprover" : { "otype" : "Admin", "mtid" : 10022176, "link" : "/api/admin/10022176", "label" : "Laczik Cecilia (SE_AOK_1Patológia_Admin5_LC, admin)", "familyName" : "Laczik", "givenName" : "Cecilia", "published" : true, "oldId" : 10022176, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000398, "link" : "/api/subtype/10000398", "label" : "Könyvfejezet (Könyvrészlet)", "name" : "Könyvfejezet", "nameEng" : "Chapter", "docType" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "listPosition" : 220, "published" : true, "oldId" : 10000398, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Montserrat, E", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 55087675, "link" : "/api/authorship/55087675", "label" : "Montserrat, E", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Montserrat", "givenName" : "E", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 98214588, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 55087676, "link" : "/api/authorship/55087676", "label" : "Campo, E", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Campo", "givenName" : "E", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 98214587, "snippet" : true } ], "title" : "Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 10987569, "link" : "/api/publicationidentifier/10987569", "label" : "DOI: 10.1016/B978-0-7216-0081-9.50029-7", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1016/B978-0-7216-0081-9.50029-7", "realUrl" : "https://doi.org/10.1016/B978-0-7216-0081-9.50029-7", "published" : false, "oldId" : 12353067, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 10987568, "link" : "/api/publicationidentifier/10987568", "label" : "Scopus: 84882882266", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "84882882266", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84882882266", "published" : false, "oldId" : 12353066, "snippet" : true } ], "firstPage" : "424", "lastPage" : "436", "firstPageOrInternalIdForSort" : "424", "pageLength" : 13, "publishedYear" : 2006, "digital" : null, "printed" : null, "sourceYear" : 2016, "packet" : "91823", "foreignEdition" : null, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-06-21", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 1, "citedCount" : 1, "referenceList" : "Müller-Hermelink, H.K., Catovsky, D., Chronic lymphocytic leukaemia/small lymphocytic lymphoma (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues., pp. 127-130. , IARC Press, Lyon, E.S. Jaffe, N.L. Harris, H. Stein (Eds.); \n\nArmitage, J.O., Weisenburger, D.D., New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes (1998) J Clin Oncol, 16, pp. 2780-2795; \n\nRozman, C., Montserrat, E., Chronic lymphocytic leukemia (1995) N Engl J Med, 333, pp. 1052-1057; \n\nKeating, M.J., Chiorazzi, N., Messmer, B., Biology and treatment of chronic lymphocytic leukemia (2003) Hematology (Am Soc Hematol Educ Program), pp. 153-175; \n\n(2000) SEER Cancer Statistics Review, 1993-1997, , National Cancer Institute, Bethesda MD, L.A.G. Ries, M.P. Eismer, C.L. Kosary (Eds.); \n\nFinch, S.C., Linet, M.S., Chronic leukaemias (1992) Baillière's Clin Haematol, 5, pp. 27-56; \n\nCuttner, J., Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia (1992) Cancer Invest, 10, pp. 103-109; \n\nRawstron, C., Yuille, R., Fuller, R., Inherited predisposition to CLL is detectable as sub-clinical monoclonal B-lymphocyte expansion (2002) Blood, 100, pp. 2289-2290; \n\nGoldin, L.R., Sgambati, M., Marti, G.E., Anticipation in familial chronic lymphocytic leukemia (1999) Am J Hum Genet, 65, pp. 265-269; \n\nRawstron, A.C., Green, M.J., Kuzmicki, A., Monoclonal B lymphocytes with the characteristics of \"indolent\" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts (2002) Blood, 100, pp. 635-639; \n\nDöhner, H., Stilgenbauer, S., Benner, A., Genomic aberrations and survival in chronic lymphocytic leukemia (2000) N Engl J Med, 343, pp. 1910-1916; \n\nDöhner, H., Stilgenbauer, S., Döhner, K., Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis (1999) J Mol Med, 77, pp. 266-281; \n\nDöhner, H., Stilgenbauer, S., Fischer, K., Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci for candidate genes (1997) Leukemia, 11 (SUPPL. 2), pp. S19-S24; \n\nStilgenbauer, S., Bullinger, L., Benner, A., Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia (1999) Leukemia, 13, pp. 1331-1334; \n\nOscier, O., Fitchett, M., Herbert, T., Karyotypic evolution in B-cell chronic lymphicytic leukemia (1991) Gene Chromosomes Cancer, 3, pp. 16-20; \n\nFegan, C., Robinson, H., Thompson, P., Karyotypic evolution in CLL: identification of a new subgroup of patients with deletions of llq and advanced or progressive disease (1995) Leukemia, 9, pp. 2003-2008; \n\nMigliazza, A., Bosch, F., Komatsu, H., Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia (2001) Blood, 97, pp. 2098-2104; \n\nBullrich, F., Fujii, H., Calin, G., Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene (2001) Cancer Res, 61, pp. 6640-6648; \n\nHamblin, T.J., Davis, Z., Gardiner, A., Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia (1999) Blood, 94, pp. 1848-1854; \n\nDamle, R.N., Wasil, T., Fais, F., Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia (1999) Blood, 94, pp. 1840-1847; \n\nRosenwald, A., Alizadeh, A.A., Widhopf, G., Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukaemia (2001) J Exp Med, 194, pp. 1639-1647; \n\nCrespo, M., Bosch, F., Villamor, N., ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia (2003) N Engl J Med, 348, pp. 1764-1775; \n\nWiestner, A., Rosenwald, A., Barry, T.S., ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile (2003) Blood, 101, pp. 4944-4951; \n\nOrchad, J.A., Ibbotson, R.W., Davis, Z., ZAP-70 expression and prognosis in chronic lymphocytic leukemia (2004) Lancet, 363, pp. 105-111; \n\nKipps, T.J., Carson, D.A., Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases (1993) Blood, 81, pp. 2475-2487; \n\nHamblin, T.J., Oscier, D.G., Young, B.J., Autoimmunity in chronic lymphocytic leukemia (1986) J Clin Pathol, 39, pp. 713-716; \n\nWard, J.H., Autoimmunity in chronic lymphocytic leukemia (2001) Curr Treat Options Oncol, 2, pp. 253-257; \n\nRozman, C., Montserrat, E., Viñolas, N., Serum immunoglobulins in B-chronic lymphocytic leukaemia. Natural history and prognostic significance (1988) Cancer, 61, pp. 279-283; \n\nPangalis, G.A., Moutsdopoulos, H.M., Papadopoulos, N.M., Monoclonal and oligoclonal immunoglobulins in the serum of patients with B-chronic lymphocytic leukemia (1988) Acta Haematol, 80, pp. 23-27; \n\nBahler, D.W., Aguilera, N.S., Chen, C.C., Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types (2000) Am J Pathol, 157, pp. 1063-1070; \n\nFend, F., Quintanilla-Martinez, L., Kumar, S., Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection (1999) Am J Pathol, 154, pp. 1857-1866; \n\nMartinez, A., Pittaluga, S., Villamor, N., Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis (2004) Am J Surg Pathol, 28, pp. 849-858; \n\nQuintanilla-Martinez, L., Thieblemont, C., Fend, F., Mantle cell lymphomas lack expression of p27Kip1, a cyclin dependent kinase inhibitor (1998) Am J Pathol, 153, pp. 175-182; \n\nAdmirand, J.H., Rassidakis, G.Z., Abruzzo, L.V., Immuno-histochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma (2004) Mod Pathol, 17, pp. 954-961; \n\nVillamor, N., Carreras, J., Colomo, L., ZAP-70 expression in B-cell lymphoid neoplasms. An immunohistochemical study (2005) J Pathol, 205, pp. 507-513; \n\nRichter, M.N., Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukaemia (1928) Am J Pathol, 4, pp. 285-292; \n\nRobertson, L.E., Pugh, W., O'Brien, S., Richter's syndrome: a report on 39 patients (1993) J Clin Oncol, 11, pp. 1985-1989; \n\nMatolcsy, A., Inghirami, G., Knowles, D.M., Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma) (1994) Blood, 83, pp. 1363-1372; \n\nBea, S., Lopez-Guillermo, A., Ribas, M., Genetic imbalances in progressed B-cell chronic lymphocytic leucemia and transformed large-cell lymphoma (Richter's syndrome) (2002) Am J Pathol, 161, pp. 957-968; \n\nGaidano, G., Ballerini, P., Gong, J.Z., P53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia (1991) Proc Natl Acad Sci USA, 88, pp. 5413-5417; \n\nCobo, F., Martinez, A., Pinyol, M., Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia (2002) Leukemia, 16, pp. 1028-1034; \n\nAbruzzo, L.V., Rosales, C.M., Medeiros, L.J., Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms (2002) Am J Surg Pathol, 26, pp. 630-636; \n\nMomose, H., Jaffe, E.S., Shin, S.S., Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus (1992) Am J Surg Pathol, 16, pp. 859-867; \n\nKanzler, H., Kuppers, R., Helmes, S., Hodgkin and Reed-Sternberg-like cells in B- cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease (2000) Blood, 95, pp. 1023-1031; \n\nEnno, A., Catovsky, D., O'Brien, M., \"Prolymphocytoid\" transformation of chronic lymphocytic leukemia (1979) Br J Haematol, 41, pp. 9-18; \n\nMolica, S., Infections in chronic lymphocytic leukemia: risk factors and impact on survival, and treatment (1994) Leuk Lymphoma, 13, pp. 203-214; \n\nMorrison, V.A., The infectious complications of chronic lymphocytic leukemia (1998) Semin Oncol, 25, pp. 98-106; \n\nGreene, M.H., Hoover, R.N., Fraumeni, J.F., Subsequent cancer in patients with chronic lymphocytic leukemia. A possible immunologic mechanism (1978) J Natl Cancer Inst, 61, pp. 337-340; \n\nHisada, M., Biggar, R.J., Greene, M.H., Solid tumors after chronic lymphocytic leukemia (2001) Blood, 98, pp. 1979-1981; \n\nChronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria (1989) Ann Intern Med, 110, pp. 236-238. , Intemational Workshop on Chronic Lymphocytic Leukemia; \n\nCheson, B.D., Bennett, J.M., Grever, M., National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment (1996) Blood, 87, pp. 4990-4997; \n\nRai, K.R., Sawitsky, A., Cronkite, E.P., Clinical staging of chronic lymphocytic leukemia (1975) Blood, 46, pp. 219-234; \n\nBinet, J.L., Auquier, A., Dighiero, G., A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis (1981) Cancer, 48, pp. 198-206; \n\nMontserrat, E., Classical and new prognostic factors in chronic lymphocytic leukemia: where to now? (2002) Hematol J, 3, pp. 7-9; \n\nMontserrat, E., Viñolas, N., Reverter, J.C., Natural history of chronic lymphocyhic leukemia: on the progression and prognosis of early clinical stages (1988) Nouv Rev Franc, 30, pp. 359-361; \n\nHallek, M., Langenmayer, I., Nerl, C., Elevated serum thymidin kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia (1999) Blood;, 93, pp. 1732-1737; \n\nReinisch, W., Wiliheim, M., Hilgarth, M., Soluble CD23 reliably reflects disease actlvity in B-cell chronic lymphocytic leukemia (1994) J Clin Oncol, 12, pp. 2146-2152; \n\nLavabre-Bertrand, T., Exbrayat, C., Bourquard, P., CD23 antigen density is related to gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukemia (1994) Leuk Lymphoma, 13, pp. 89-94; \n\nManshouri, T., Do, K.A., Wang, X., Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukaemia and is of prognostic significance (2003) Blood, 101, pp. 2507-2513; \n\nEl Rouby, S., Thomas, A., Costin, D., P53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1 /MDR3 gene expression (1993) Blood, 82, pp. 3452-3459; \n\nCatovsky, D., Fooks, I., Richards, S., Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex, and response to treatment in survival (1989) Br J Haematol, 72, pp. 141-149; \n\nMauro, F.R., Foa, R., Cerretti, R., Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clincial, therapeutic, and prognostic features (2000) Blood, 95, pp. 2788-2792; \n\nHamblin, T.J., Orchad, J.A., Ibbotson, R.E., CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease (2002) Blood, 99, pp. 1023-1029; \n\nDighiero, G., Maloum, K., Desablens, B., Chlorambucil in indolent chronic lymphocytic leukemia (1998) N Engl J Med, 338, pp. 1506-1511; \n\nChemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group (1999) J Natl Cancer Inst, 91, pp. 861-868; \n\nJohnson, S., Smith, A.G., Multicentre prospective randomized trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukemia (1996) Lancet, 347, pp. 1432-1438. , The French Cooperative Group on CLL; \n\nRai, K.R., Peterson, B.L., Appelbaum, F.R., Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia (2000) N Engl J Med, 343, pp. 1750-1757; \n\nLeporrier, M., Chevret, S., Cazin, B., Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients (2001) Blood, 98, pp. 2319-2325; \n\nBosch, F., Ferrer, A., Lopez-Guillermo, A., Fludarabine, cyclophosphamide, and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia (2002) Br J Haematol, 119, pp. 976-984; \n\nEichorst, B.F., Busch, R., Hopfinger, G., Fludarabine plus cyclophosphamide (FC) induces higher remission rates and longer progression free survival than fludarabine (F) alone in first-line therapy of advanced chronic lymphocytic leukemia (CLL): results of a Phase III study (CLL4 protocol) of the German Study Group (GCLLSG) (2003) Blood, 102. , [abstract 243]; \n\nWierda, W., O'Brien, S., Faderi, S., Improved survival in patients with relapsed-refractory chronic lymphocytic leukemia (CLL) treated with fludarabine, cyclophosphamide, and rituximab (FCR) combination (2003) Blood, 102. , [abstract 373]; \n\nByrd, J.C., Peterson, B.L., Morrison, V.A., Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712) (2003) Blood, 101, pp. 6-14; \n\nCheson, B.D., Infectious and immunosuppresive complications of purine analog therapy (1995) J Clin Oncol, 13, pp. 2431-2448; \n\nDi Raimondo, F., Giustolisi, R., Cacciola, E., Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine (1993) Leuk Lymphoma, 11, pp. 63-68; \n\nHurst, P.G., Habib, M.P., Garewall, H., Pulmonary toxicity associated with fludarabine monophosphate (1987) Invest New Drugs, 5, pp. 207-210; \n\nCervantes, F., Salgado, C., Montserrat, E., Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis (1990) Lancet, 2, p. 1130; \n\nFrame, J.N., Dahut, W.L., Crowley, S., Fludarabine and acute tumor lysis in chronic lymphocytic leukemia (1992) N Engl J Med, 327, p. 1396; \n\nPalomera, L., Azaceta, G., Varo, M.J., Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma (1998) Haematologica, 83, pp. 1045-1046; \n\nPaydas, S., Disel, U., Yavuz, S., Fludarabine as the possible cause of acute myelofibrosis (2004) Hematol J, 5, pp. 283-284; \n\nMaung, Z.T., Wood, A.C., Jackson, G.H., Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia (1994) Br J Haematol, 88, pp. 649-652; \n\nBriz, M., Cabrera, R., Sanjuan, I., Diagnosis of transfusion-associated graft versus-host disease by polymerase chain reaction in fludarabine treated B-chronic lymphocytic leukaemia (1995) Br J Haematol, 91, pp. 409-411; \n\nMorrison, V.A., Rai, K.R., Peterson, B.L., Therapy-related leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study of the Cancer and Leukemia Group B 9011 (2002) J Clin Oncol, 20, pp. 3878-3884; \n\nOrchad, J.A., Bolam, S., Oscier, D.G., Association of myelodysplastic syndromes with purine analogues (1998) Br J Haematol, 100, pp. 677-679; \n\nMajumdar, C., Singh, A.K., Role of splenectomy in chronic lymphocytic leukaemia with massive splenomegaly and cytopenia (1992) Leuk Lymphoma, 7, pp. 131-134; \n\nChikkappa, G., Pasquale, D., Zarrabi, M.H., Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia (1992) Am J Hematol, 41, pp. 5-12; \n\nIntravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial (1988) N EngI J Med, 319, pp. 902-907. , Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia; \n\nWeeks, J.C., Tiemey, M.R., Weinstein, M.C., Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia (1991) N Engl J Med, 325, pp. 81-86; \n\nHollander, A.A.M.J., Kluin-Nelemans, H.C., Haak, H.R., Correction of neutropenia associated with chronic lymphocytic leukemia following treatment with granulocyte-macrophage colony stimulating factor (1991) Ann Hematol, 62, pp. 32-34; \n\nStraus, D.J., Epoetin alfa therapy for patients with hematologic malignancies and mild anemia (2003) Clin Lymphoma, (SUPPL. 1), pp. S13-S17; \n\nTallman, M.S., Monoclonal antiboidy therapies in leukemias (2002) Semin Hematol, 39 (SUPPL. 3), pp. 12-19; \n\nOsterborg, A., Dyer, M.J., Bunjes, D., Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia (1997) European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia J Clin Oncol, 4, pp. 1567-1574; \n\nOsterborg, A., Fassas, A.S., Anagnostopoulos, A., Humanized CD52 monoclonal antibody Campath-1H as first line treatment in chronic lymphocytic leukemia (1996) Br J Haematol, 93, pp. 151-153; \n\nDyer, M.J., Kelsey, S.M., Mackay, H.J., In vivo \"purging\" of residual disease in CLL with Campath-1H (1997) Br J Haematol, 97, pp. 669-672; \n\nHuhn, D., von Schilling, C., Wilhelm, M., Rituximab therapy of patients with B-cell chronic lymphocytic leukemia (2001) Blood, 98, pp. 1326-1331; \n\nMavromaties, B.H., Cheson, B.D., Novel therapies for chronic lymphocytic leukemia (2004) Blood Rev, 18, pp. 137-148; \n\nEsteve, J., Villamor, N., Colomer, D., Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status (2001) Leukemia, 15, pp. 445-451; \n\nDreger, P., Montserrat, E., Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia (2002) Leukemia, 16, pp. 985-992; \n\nSchetelig, J., Thiede, C., Bornhäuser, M., Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group (2003) J Clin Oncol, 21, pp. 2747-2753; \n\nDreger, P., Brand, R., Hansz, J., Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning (2003) Leukemia, 17, pp. 841-848; \n\nRitgen, M., Lange, A., Stilgenbauer, S., Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia (2003) Blood, 101, pp. 2049-2053; \n\nDreger, P., Stilgenbauer, S., Benner, A., The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the V H gene mutational status (2004) Blood, 103, pp. 2850-2858", "hasCitationDuplums" : false, "userChangeableUntil" : "2016-05-24T11:22:43.000+0000", "publishDate" : "2016-05-24T11:22:38.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 1, "ownerInstituteCount" : 10, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "book" : { "otype" : "Book", "mtid" : 30122033, "link" : "/api/publication/30122033", "label" : "The Lymphomas. (2006) ISBN:9780721600819", "core" : false, "citation" : false, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "title" : "The Lymphomas", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 6723519, "link" : "/api/publicationidentifier/6723519", "label" : "ISBN: 9780721600819", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9780721600819", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9780721600819", "published" : false, "snippet" : true } ], "publishedAt" : [ ], "publishedYear" : 2006, "foreignLanguage" : true, "fullPublication" : false, "conferencePublication" : true, "published" : true, "snippet" : true }, "hasQualityFactor" : false, "link" : "/api/publication/25749999", "label" : "Montserrat E et al. Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia. (2006) Megjelent: The Lymphomas pp. 424-436", "template" : "